Global Contraceptive Market

Report ID : 1494 | Published : 2022-12-14 | Pages: | Format: PDF/EXCEL

The market size of the Global Contraceptive Market in the year 2021 is valued at 27.41 billion and is predicted to reach 49.60 billion by the year 2030 at an 7.02% CAGR during the forecast period.

The use of contraception has increased, which has improved health outcomes, such as maternal and newborn mortality, and reduced the risk of STDs. Additionally, it is projected that an increase in the number of gynecologists who support these contraceptive methods for birth control would fuel business expansion in the coming years. The market projections for contraceptives consider factors such as rising awareness of modern contraceptives, rising use of secure and reliable oral pills, and health concerns associated with teen pregnancies. Female contraceptives currently dominate the market, but as more men use condoms, the demand for male contraceptives will rise. Serious adverse effects include liver diseases, gallbladder illness, heart attacks, and blood clots in the legs. Over the foreseeable period, sales will be constrained by these contraceptive-related side effects. The market may be expanding due to various issues, such as increased consumer knowledge of STDs, unwanted pregnancies, and population control. These factors will cause the need for contraceptives to skyrocket, especially in emerging nations. There is a considerable likelihood that the market will expand thanks to the arrival of new vendors and the growing accessibility of sophisticated contraception techniques greatly. Retail pharmacies will continue to dominate the industry due to manufacturers' improved supply chain networks.

Market Segmentation:

The contraceptive market is segmented into Products (drugs and devices). Based on drugs, the market is segmented into oral contraceptive pills, injectable contraceptives and topical contraceptives. Based on devices, the contraceptive market is segmented into condoms (male, female), diaphragms, contraceptive sponges, vaginal rings, subdermal implants and intra-uterine devices (copper, hormonal).

Based on contraceptive drugs, the contraceptive pills segment is a major contributor to the Contraceptive market.

The market's leading segment is contraceptive pills. The main purposes of contraception pills are to prevent unintended pregnancies, regulate birth rates, and reduce the risk of sexually transmitted diseases. As a result, it will increase in the years to come. Additionally, rising contraceptive use among young women and higher education levels supports the growth of the contraceptive drugs market.

The vaginal ring segment witnessed growth at a rapid rate

The vaginal ring segment is predicted to develop significantly during the forecast period. The segment is growing due to factors including cost-effectiveness and long product life cycles. The availability of new goods and the simplicity of using vaginal rings are anticipated to increase demand for these birth control methods.

The North American contraceptive market holds a significant revenue share in the region.

The North American Contraceptive market is expected to register the highest market share. Favourable government programs, a high proportion of unwanted pregnancies, a rise in the prevalence of sexually transmitted illnesses, etc. The U.S. government has launched several education campaigns about family planning and contraception, which have boosted the sector's income. In the United States, there are many unwanted pregnancies. Besides, Asia Pacific had a substantial share of the Contraceptive market. The region's demand for contraceptives is expected to grow due to increased government activities. The market in the Asia Pacific is also anticipated to be driven by an increase in unwanted pregnancies and improved family planning awareness.

Competitive Landscape

Some major key players in the Contraceptive market are Bayer AG; China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu); Cupid Ltd.; Helm AG; Church & Dwight; Organon Group Of Companies; Pfizer Inc.; Viatris (Mylan); Abbvie, Inc.; Afaxys, Inc.; Agile Therapeutics; Janssen Pharmaceuticals, Inc.; Veru, Inc.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Contraceptive Market Snapshot

Chapter 4. Global Contraceptive Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: by Product Type Estimates & Trend Analysis

5.1. by Product Type & Market Share, 2019 & 2030

5.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2019 to 2030 for the following by Product Type:

5.2.1. Contraceptive Drugs

5.2.1.1. Contraceptive Pills

5.2.1.2. Patch

5.2.1.3. Injectables

5.2.2. Contraceptive Devices

5.2.2.1. Condoms

5.2.2.1.1. Male Condoms

5.2.2.1.2. Female Condoms

5.2.2.2. Subdermal Implants

5.2.2.3. IUDs

5.2.2.3.1. Copper IUDs

5.2.2.3.2. Hormonal IUDs

5.2.2.4. Vaginal Rings

5.2.2.5. Diaphragm

Chapter 6. Contraceptive Market Segmentation 2: Regional Estimates & Trend Analysis

6.1. North America

6.1.1. North America Contraceptive Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2019-2030

6.1.2. North America Contraceptive Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2030

6.2. Europe

6.2.1. Europe Contraceptive Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2019-2030

6.2.2. Europe Contraceptive Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2030

6.3. Asia Pacific

6.3.1. Asia Pacific Contraceptive Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2019-2030

6.3.2. Asia Pacific Contraceptive Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2030

6.4. Latin America

6.4.1. Latin America Contraceptive Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2019-2030

6.4.2. Latin America Contraceptive Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2030

6.5. Middle East & Africa

6.5.1. Middle East & Africa Contraceptive Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2019-2030

6.5.2. Middle East & Africa Contraceptive Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2030

Chapter 7. Competitive Landscape

7.1. Major Mergers and Acquisitions/Strategic Alliances

7.2. Company Profiles

7.2.1. Bayer AG

7.2.2. China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu)

7.2.3. Cupid Ltd.

7.2.4. Helm AG

7.2.5. Church & Dwight

7.2.6. Organon Group Of Companies

7.2.7. Pfizer Inc.

7.2.8. Viatris (Mylan)

7.2.9. Abbvie, Inc.

7.2.10. Afaxys, Inc.

7.2.11. Veru, Inc.

7.2.12. Agile Therapeutics

7.2.13. Janssen Pharmaceuticals, Inc.

7.2.14. Other Prominent Players

By Products

  • Contraceptive Drugs
    • Contraceptive Pills
    • Patch
    • Injectables
  • Contraceptive Devices
    • Condoms
      • Male Condoms
      • Female Condoms
    • Subdermal Implants
    • IUDs
      • Copper IUDs
      • Hormonal IUDs
    • Vaginal Rings
    • Diaphragm

By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

Need Complete Report ?
Our Clients